Mercury Laboratories Limited

BSE: MERCURYLAB538964ISIN INE947G01011

Healthcare
Pharmaceuticals

BSE listing

Share price

₹780.00-1.00 (-0.13%)

as of 18 Sep 2026

52W high: ₹942.90
52W low: ₹620.55
Off 52W high: -17.28%
1M return: +0.63%
3M return: -8.31%
6M return: -0.05%
1Y return: -7.25%
20D avg volume: 34
50 DMA: ₹793.69
200 DMA: ₹804.85

Key ratios Standalone

Market cap: ₹93.60 Cr
Current price: ₹780.00
52W high / low: ₹942.90 / ₹620.55
Face value: ₹10.00
P/E: 22.48
P/B: 1.81
EPS (TTM): ₹34.70
Book value / share: ₹430.94
ROE: 8.05%
ROCE: 10.70%
Operating margin: 7.79%
Net margin: 1.87%
Debt / equity: 0.13
Net debt: ₹6.61 Cr
Interest cover: 13.30
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 128.4 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	15.96	20.44	18.35	19.01	18.14	20.66	—
	0.05	0.67	0.31	0.79	0.18	0.18	—
	15.62	19.38	16.84	17.88	16.77	19.40	—
	5.79	6.90	6.30	6.22	5.94	8.15	—
	0.65	0.75	0.58	0.61	0.34	0.69	—
	4.24	4.57	4.17	4.45	4.24	4.36	—
	0.12	0.13	0.14	0.13	0.15	0.13	—
	0.73	0.84	0.87	0.86	0.84	0.73	—
	4.44	5.98	4.62	5.05	4.29	6.12	—
	0.39	1.74	1.82	1.92	1.55	1.45	—
	0.00	0.00	-0.39	0.00	0.00	0.00	—
	0.39	1.74	1.43	1.92	1.55	1.45	—
	0.09	0.51	0.43	0.28	0.58	0.34	—
	0.30	1.23	1.00	1.64	0.97	1.11	—
	2.48	10.21	8.31	13.69	8.06	9.25	—
Key metrics
	1.24	2.71	2.44	2.91	2.54	2.31	—
	7.80%	13.30%	13.30%	15.30%	14.00%	11.20%	—
	1.90%	6.00%	5.40%	8.60%	5.30%	5.40%	—
	—	2.80%	—	3.30%	—	2.70%	—
	-12.00%	-1.10%	—	—	—	—	—
	-69.10%	10.80%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	73.76	75.94	75.10	—
	1.82	1.96	1.07	—
	69.72	70.86	71.51	—
	25.21	25.36	27.45	—
	2.59	2.28	2.21	—
	17.43	17.44	16.84	—
	0.52	0.54	0.55	—
	3.30	3.42	2.88	—
	20.09	19.94	22.33	—
	5.87	7.03	4.66	—
	-0.39	-0.39	0.00	—
	5.48	6.64	4.66	—
	1.31	1.80	1.52	—
	4.17	4.83	3.14	—
	34.69	40.28	26.21	—
Key metrics
	9.30	10.60	8.09	—
	12.61%	14.00%	10.80%	—
	5.65%	6.40%	4.20%	—
	—	10.70%	8.80%	—
	—	1.10%	—	—
	—	53.80%	—	—
	—	1.07	-5.04	—
	—	0.88	1.27	—
	—	0.13	0.08	—
	—	6.61	3.76	—
	—	128.4	112.3	—
Balance sheet
	—	79.08	74.24	—
	—	44.95	40.08	—
	—	0.80	0.33	—
	—	25.85	25.74	—
	—	7.12	7.21	—
	—	5.53	4.72	—
	—	23.88	24.62	—
	—	6.24	9.83	—
	—	11.69	15.08	—
	—	7.41	4.09	—
	—	0.67	1.05	—
	—	6.74	3.04	—
	—	58.08	53.57	—
Cash flow
	—	4.24	4.00	—
	—	-3.17	-9.04	—
	—	2.91	-0.99	—
	—	3.17	9.04	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 73.67%

Holder	Type	Holding	Previous	Change
Shah Dilip Ramanlal HUF	Promoter Group	25.88%	—	—
Shah Rajendra Ramanlal Huf	Promoter Group	17.42%	—	—
Janki Rajendra Shah	Promoter Group	8.67%	—	—
Shah Rajendrakumar Ramanlal	Promoter	7.14%	—	—
Dilip Ramanlal Shah	Promoter	7.07%	—	—
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs	Public	6.40%	—	—
Rajeshri Ketan Shah	Public	2.20%	—	—
Paresh Ramanlal Shah	Promoter Group	1.97%	—	—
Kaumudini Rajendra Shah	Promoter Group	1.76%	—	—
Bharti Bharat Dattani	Public	1.64%	—	—
Jeet Ketan Shah	Public	1.31%	—	—
Adit Dilipbhai Shah	Promoter Group	1.29%	—	—
Bimal Ramanlal Shah	Promoter Group	1.17%	—	—
Sharad Kanayalal Shah	Public	1.11%	—	—
Parulben Kiranbhai Laliwala	Promoter Group	1.02%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Intimation for appointment of Manager HR as senior Management is attched3 Sep 2026 · Company Update / Change in Management
Submission of Newspaper publication of 45th AGM notice of the Company scheduled to be held on September 28, 20262 Sep 2026 · Company Update / Newspaper Publication
Please find enclosed herewith a copy of 45th Annual Report of the Company for the Financial Year ended March 31, 2026.1 Sep 2026 · Others / Reg. 34 (1) Annual Report
Please find enclosed herewith a copy of 45th AGM notice of the Company scheduled to be held on 28/09/2026 at 11.30 AM IST1 Sep 2026 · AGM/EGM / AGM
Newspaper publication regarding 45th AGM to be held on September 28, 2026 is attached27 Aug 2026 · Company Update / Newspaper Publication
Intimation regarding appointment of Mr. Sunil Sharma and resignation of Ms. Seema Salvi as HOD injectable21 Aug 2026 · Company Update / Change in Management
Communication to Shareholders on TDS on the dividend for the FY 25-26 is attached20 Aug 2026 · Company Update / General
Newspaper advertisement of unaudited financial result for the quarter ended on June 2026 is attched27 Jul 2026 · Company Update / Newspaper Publication
Unaudited Financial results for the quarter ended on June 30, 2026 is attched25 Jul 2026 · Result / Financial Results
Outcome of meeting for approval of the unaudited financial statement for the quarter ended on June 30, 2026 is attched25 Jul 2026 · Board Meeting / Outcome of Board Meeting
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider and approve the Unaudited Financial ....16 Jul 2026 · Board Meeting / Board Meeting
Certificate of Compliance under Reg 74(5) of SEBI(DP) Reg, 2018 for the quarter ended on June 30, 2026 is attached6 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed Newspaper advertisement regarding notice Second 100 days campaign saksham niveshak and special window for dematerialisation of physcial securtites4 Jul 2026 · Company Update / Newspaper Publication
Intimation regarding Credit Rating on Fixed deposit is attached1 Jul 2026 · Company Update / Credit Rating
Intimation of Closure of Trading window for the announcement of unaudited Financial Results for the quarte ended on June 30, 2026 is attached25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation about the appointment of Plant head is attached11 Jun 2026 · Company Update / Change in Management
Newspaper publication of audited financial statement for the quarter and year ended on 31.03.2026 is attached31 May 2026 · Company Update / Newspaper Publication
Corrigendum to audited financial statement results for the quarter and year ended on 31.03.2026 is attached29 May 2026 · Company Update / General
Details of Appointment of Internal Auditor and Cost auditor is attached29 May 2026 · Company Update / Change in Management
book colusre intimation for 45th AGM and Dividend is attached29 May 2026 · Company Update / General
Recommendation of Dividend by the Board for the FY 2025-2629 May 2026 · Corp. Action / Dividend
Audited Financial results for the year ended on March 31, 2026 along with auditors report is attached29 May 2026 · Result / Financial Results
Outocme of Board Meeting held on May 29, 2025 is attached29 May 2026 · Board Meeting / Outcome of Board Meeting
Annual Secretarial Compliance report for the FY 25-26 is attached28 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial ....23 May 2026 · Board Meeting / Board Meeting
Intimation of Newspaper advertisement regarding notice of transfer of shares to IEPFA and special window for dematerialization of physical transfer8 May 2026 · Company Update / Newspaper Publication
Intimation to shareholder relating to transfer of Equity shares to IEPFA is attached7 May 2026 · Company Update / General
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....29 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Intimation of Resignation of SM Plant head jarod attched29 Apr 2026 · Company Update / Change in Management
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....29 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Certificate under Reg 74(5) of SEBI(DP) Reg, 2018 for the quarter ended on March 31, 2026 is attched6 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of closure of Trading window for the announcement of audited finacial results for the quarter and financial year ending of March 31, 202625 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Submission of newspaper publication of unaudited financial results for the quarter and nine months ended on December 31, 202513 Feb 2026 · Company Update / Newspaper Publication
Unaudited Financial Results as on December 31, 2025 is attached11 Feb 2026 · Result / Financial Results
Outcome of Board Meeting held on February 11, 2026 is attached11 Feb 2026 · Board Meeting / Outcome of Board Meeting
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Unaudited Financial Results ....4 Feb 2026 · Board Meeting / Board Meeting
Compliance certificate under Reg 74(5) SEBI(DP) Reg , 2018 for the quarter ended on December 31, 2025 is attached3 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation for Closure of Trading Window for the announcement unaudited Financial Results for the quarter and nine months ended on Dec 31, 2025 is attached25 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Intimation about additional charge assigned to Mr. Saurabh Mittal as VP-marketing & Sales is attached17 Nov 2025 · Company Update / Change in Management
Newspaper publication of unaudited financial results for the quarter and half year ended on September 30, 2025 is attached13 Nov 2025 · Company Update / Newspaper Publication

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 3.5000	6 Aug 2025	6 Aug 2025	—
Final Dividend - Rs. - 3.5000	20 Sep 2024	—	—

Board meetings

25 Jul 2026 Board Meeting - Financial Results